We take the opportunity of the World Obesity Day 2021 to launch the first YSOPIA’s podcast hosted by our CSO Dr Sandrine Claus.
> Discover Yso1, YSOPIA’s clinical stage development program aiming at harnessing the potential of Christensenella minuta as a groundbreaking biotherapy to treating obesity and associated metabolic disorders.
In the same category
YSOPIA Successfully Completes Phase 1 Clinical Study of Xla1 Biotherapy for the Treatment of Obesity...
Jul 6, 2021more +
90 seconds to learn more about YSOPIA Bioscience
Jun 1, 2021more +
We are looking for a Senior Scientist in Microbiology & Biotechnology – Team Leader...
May 4, 2021more +